BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35194945)

  • 1. Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis.
    Karampinis I; Dionysopoulou A; Galata C; Almstedt K; Grilli M; Hasenburg A; Roessner ED
    Thorac Cancer; 2022 Apr; 13(7):883-888. PubMed ID: 35194945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
    Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion.
    Li Z; Deng J; Yan F; Liu L; Ma Y; Sun J
    Sci Rep; 2023 Jul; 13(1):12071. PubMed ID: 37495659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
    Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
    Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial.
    Liu L; Zhang T; Song X; Liao CG; Xu T; Yang Y; Zeng M; Jia J; Su H; Song Y; Min J; Zhang H; Li W; Zhang H; Zhang H
    Int J Hyperthermia; 2023; 40(1):2241689. PubMed ID: 37574198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Sakaguchi H; Ishida H; Nitanda H; Yamazaki N; Kaneko K; Kobayashi K
    Lung Cancer; 2017 Feb; 104():70-74. PubMed ID: 28213004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the diagnosis and management of malignant pleural effusions.
    Heffner JE; Klein JS
    Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
    Porcel JM; Solé C; Salud A; Bielsa S
    Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial.
    Kleontas A; Sioga A; Pandria N; Barbetakis N; Lazopoulos A; Katsikas I; Asteriou C; Paliouras D; Kamperis E; Ikonomou D; Papamitsou T; Filippou D; Destouni C; Ikonomou L; Zarogoulidis K; Papagiannopoulos K
    J Thorac Dis; 2019 May; 11(5):1788-1798. PubMed ID: 31285871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
    Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
    Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
    Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
    Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0-N1 nonsmall cell lung cancer and malignant pleural effusion?
    Migliore M; Nardini M
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31366459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
    Kang M; Zhou L; Lin P
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion.
    Shoji T; Tanaka F; Yanagihara K; Inui K; Wada H
    Chest; 2002 Mar; 121(3):821-4. PubMed ID: 11888966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ; Cao YP; Deng F
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of malignant pleural effusions.
    Heffner JE
    Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.